Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-026172
Filing Date
2016-08-03
Accepted
2016-08-03 12:05:18
Documents
2
Period of Report
2016-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 56335
2 EX-99.1 DOCUMENT attachment1.htm EX-99.1 6212
  Complete submission text file 0000899243-16-026172.txt   65098
Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022 2128473500
GOLDENTREE ASSET MANAGEMENT LP (Reporting) CIK: 0001278951 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37841 | Film No.: 161802890

Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address
Tananbaum Steven A. (Reporting) CIK: 0001435626 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37841 | Film No.: 161802888

Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022 212-847-3500
GoldenTree Asset Management LLC (Reporting) CIK: 0001435627 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37841 | Film No.: 161802889

Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Issuer) CIK: 0001557142 (see all company filings)

EIN.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations